Synthesis of 200G compound NCGC00413972
Ended Purchase Order Awarded Last action
- Contract number
- 75N95023P00738
- Awardee
-
Karebay Biochem Inc. UEI ZKCBGTN8DJH7
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $19,800
Award facts
- Opportunity
-
- 75N95023Q00589 Solicitation number
- Contract value 100% obligated
- $19,800.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Monmouth Junction, South Brunswick Township, NJ 08852, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a $19,800 firm fixed price purchase order to Karebay Biochem Inc., a for-profit small business, to synthesize 200 grams of compound NCGC00413972. This order supports NIH's biomedical research programs, particularly in the areas of drug discovery and infectious disease. Karebay Biochem has received multiple prior purchase orders from NIH entities to provide chemical synthesis services, including a $28,000 order for a 408 peptide library. The contract award was not designated as a set-aside.
Quick answers
Who was awarded contract 75N95023P00738?
75N95023P00738 was awarded to Karebay Biochem Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 8, 2023.
How much is contract 75N95023P00738 worth?
The government has obligated $19,800 on 75N95023P00738.
Which agency awarded contract 75N95023P00738?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95023P00738, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95023P00738 competed?
The extent of competition for 75N95023P00738 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award